StreetInsider.com News Articles

Shattuck Labs (STTK) PT Lowered to $14 at H.C. Wainwright

Wed, 12 Aug 2026 07:27:15 -0400

(Updated - August 12, 2026 7:27 AM EDT)

H.C. Wainwright analyst Joseph Pantginis lowered the price target on Shattuck Labs (NASDAQ: STTK) to $14.00 (from $18.00) while maintaining a Buy rating.

The analyst commented: "Shattuck announced 2Q26 financial results on August 11. During the quarter, the company made significant progress in advancing its lead asset, SL-325, building on the Phase 1 healthy volunteer data reported in June, which demonstrated a best-in-mechanism immunogenicity profile, durable DR3 blockade, and a favorable safety profile, into a confirmed lead indication in Crohn's disease, with the RECEPTIVE-CD1 Phase 2b design expanded to a three-dose, ~232-patient structure from

Shattuck Labs (STTK) PT Lowered to $14 at H.C. Wainwright

Wed, 12 Aug 2026 07:27:15 -0400

(Updated - August 12, 2026 7:27 AM EDT)

H.C. Wainwright analyst Joseph Pantginis lowered the price target on Shattuck Labs (NASDAQ: STTK) to $14.00 (from $18.00) while maintaining a Buy rating.

Form S-8 Shattuck Labs, Inc.

Tue, 11 Aug 2026 07:39:00 -0400

si-local-file:///var/storage/secattach/20260811/26901499.html

Form S-8 Shattuck Labs, Inc.

Tue, 11 Aug 2026 07:39:00 -0400

si-local-file:///var/storage/secattach/20260811/26901499.html

Form 8-K Shattuck Labs, Inc. For: Aug 11

Tue, 11 Aug 2026 06:59:00 -0400

si-local-file:///var/storage/secattach/20260811/26900997.html

Form 8-K Shattuck Labs, Inc. For: Aug 11

Tue, 11 Aug 2026 06:59:00 -0400

si-local-file:///var/storage/secattach/20260811/26900997.html

Form 10-Q Shattuck Labs, Inc. For: Jun 30

Tue, 11 Aug 2026 06:57:00 -0400

si-local-file:///var/storage/secattach/20260811/26900982.html

Form 10-Q Shattuck Labs, Inc. For: Jun 30

Tue, 11 Aug 2026 06:57:00 -0400

si-local-file:///var/storage/secattach/20260811/26900982.html

Shattuck Labs, Inc. (STTK) Tops Q2 EPS by 1c

Tue, 11 Aug 2026 06:37:41 -0400

Shattuck Labs, Inc. (NASDAQ: STTK) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Shattuck Labs, Inc. (STTK) click here.

Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Tue, 11 Aug 2026 06:15:00 -0400

– Phase 1 clinical trial results for SL-325 demonstrated a favorable safety profile, a potentially best-in-mechanism immunogenicity profile, and durable DR3 blockade of TL1A binding, potentially enabling prolonged dosing intervals –

– RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter of 2026 –

– Announced lead DR3 x IL-23 receptor blocking, half-life extended bispecific antibody product candidate, SL-846, with initial Phase 1 clinical data expected in 2027 –

–Strengthened balance sheet with approximately $208.3 million in cash and cash equivalents and short-term

Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Tue, 11 Aug 2026 06:15:00 -0400

– Phase 1 clinical trial results for SL-325 demonstrated a favorable safety profile, a potentially best-in-mechanism immunogenicity profile, and durable DR3 blockade of TL1A binding, potentially enabling prolonged dosing intervals –

– RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter of 2026 –

– Announced lead DR3 x IL-23 receptor blocking, half-life extended bispecific antibody product candidate, SL-846, with initial Phase 1 clinical data expected in 2027 –

–Strengthened balance sheet with approximately $208.3 million in cash and cash equivalents and short-term

JPMorgan Reiterates Overweight Rating on Shattuck Labs (STTK)

Fri, 24 Jul 2026 01:54:46 -0400

JPMorgan analyst Brian Cheng reiterated an Overweight rating and $10.00 price target on Shattuck Labs (NASDAQ: STTK)
The analyst comments: “We are initiating coverage on Shattuck (STTK) with an OW rating and a Dec 2027 PT of $10. STTK is a clinical-stage biotech developing an anti-DR3 antibody program (SL-325) within the familiar TL1A axis (see our TL1A debrief). While the TL1A axis has emerged as a validated MoA to tackle I&I diseases, such as IBD, STTK is pursuing a differentiated strategy to tackle the same axis by targeting the associated receptor. We believe the HV data reported last month are encouraging,

Leerink Starts Shattuck Labs (STTK) at Outperform

Mon, 20 Jul 2026 06:05:01 -0400

Leerink initiates coverage on Shattuck Labs (NASDAQ: STTK) with a Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Shattuck Labs click here. For more ratings news on Shattuck Labs click here.
Shares of Shattuck Labs closed at $7.53 yesterday.

Form SCHEDULE 13D/A Shattuck Labs, Inc. Filed by: Redmile Group, LLC

Fri, 17 Jul 2026 21:30:00 -0400
si-local-file:///var/storage/secattach/20260717/26785524.html

Form SCHEDULE 13D/A Shattuck Labs, Inc. Filed by: Redmile Group, LLC

Fri, 17 Jul 2026 21:30:00 -0400
si-local-file:///var/storage/secattach/20260717/26785524.html

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Shutterstock and Getty Images merger terminated after CMA conditions

Thu, 09 Jul 2026 06:06:18 -0400
(Updated - July 9, 2026 6:06 AM EDT)
Shutterstock, Inc. and Getty Images Holdings, Inc. have terminated their planned merger after the U.K. Competition and Markets Authority (CMA) conditioned its clearance on the sale of Shutterstock's editorial business.
The merger agreement, originally announced on January 6, 2025, was terminated on July 7, 2026, following a decision by Getty Images' board of directors to not proceed with the required editorial business sale under CMA supervision.
Getty Images' board unanimously resolved to terminate the merger agreement after the Second Extended End Date passed on July 6, 2026. The decision was disclosed in a Current Report

Form 4 Shattuck Labs, Inc. For: Jul 02 Filed by: Shukla Abhinav A.

Tue, 07 Jul 2026 19:00:00 -0400
si-local-file:///var/storage/secattach/20260707/26743003.html

Form 4 Shattuck Labs, Inc. For: Jul 02 Filed by: Shukla Abhinav A.

Tue, 07 Jul 2026 19:00:00 -0400
si-local-file:///var/storage/secattach/20260707/26743003.html

Form 4 Shattuck Labs, Inc. For: Jun 30 Filed by: Shukla Abhinav A.

Thu, 02 Jul 2026 20:17:00 -0400
si-local-file:///var/storage/secattach/20260702/26730192.html

Form 4 Shattuck Labs, Inc. For: Jun 30 Filed by: Shukla Abhinav A.

Thu, 02 Jul 2026 20:17:00 -0400
si-local-file:///var/storage/secattach/20260702/26730192.html